PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28102729-0	2017	Chronic myelomonocytic leukemia with double-mutations in DNMT3A and FLT3-ITD treated with decitabine and sorafenib.	Decitabine	90-100	fms related receptor tyrosine kinase 3	Homo sapiens	68-72	
28102729-3	2017	We reported a 51-year-old man who had CMML with concomitant mutations in DNMT3A and FLT3-ITD.The patient received decitabine and sorafenib combined treatment.	Decitabine	114-124	fms related receptor tyrosine kinase 3	Homo sapiens	84-92